Trial site
Centrum Medyczne Hope Clinic Sebastian Szklener
- 16running trials
- 11closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Conditions
- Myasthenia gravis7 trials
- Migraine6 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)5 trials
- Parkinson disease3 trials
- Graves' disease2 trials
- Lung cancer2 trials
- Diabetic neuropathy1 trial
- Multiple sclerosis1 trial
- Phase
- Phase 314 trials
- Phase 210 trials
- Phase 13 trials
- Status
- Completed10 trials
- Recruiting8 trials
- Active, not recruiting5 trials
- Not yet recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Immunovant Sciences GmbH6 trials
- AbbVie4 trials
- Amgen4 trials
- Pfizer2 trials
- UCB Biopharma SRL2 trials
- and 9 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Recruiting
A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
Recruiting
Recruiting
Recruiting
Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Recruiting
Active, not recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Recruiting
Active, not recruiting
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myasthenia gravis5 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
- Graves' disease2 recruiting
- Migraine1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Completed
Safety, Tolerability, and Efficacy of NVG-2089 in Participants with CIDP
Completed
A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP
Active, not recruiting
Completed
Completed
Completed
Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP.
Terminated
Completed
Completed
Completed
Completed
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
Site data: ClinicalTrials.govUpdated 17 Nov 2026